Silver nanoparticles |
(Qasim et al., 2015) |
Hydroxyl |
30-50 |
– |
Bacillus sp, C. albicans, E. coli, K. pneumoniae, P. aeruginosa and S. aureus
|
Antibacterial |
Ag-embedded mesoporous silica nanoparticles |
(Divya et al., 2019) |
– |
15 - 50 AgNps/400 mSiO2 |
– |
C. albicans |
Antifungal |
Silver nanoparticles |
(Mishra et al., 2018) |
Phenolic compounds |
<100 |
– |
S. aureus, E. faecalis, A. baumannii, Citrobacter freundii, Enterobacter aerogenes, E. coli, K. oxytoca, K. pneumoniae, P. mirabilis, P. vulgaris, and P. aeruginosa
|
Antibacterial |
Silver nanoparticles |
(Shafreen et al., 2017) |
N. palea aminoacids and proteins |
70–90 |
– |
E. coli
|
Antibiofilm |
Piper betle based silver nanoparticles |
(Srinivasan et al., 2018) |
Amide |
156.4 |
− 23.1 |
S. marcescens and P. mirabilis
|
Antibiofilm |
Antiquorum sensing |
Silver nanoparticles |
(Meenakumari et al., 2000) |
– |
87 |
– |
P. aeruginosa, K. pneumoniae, E. faecalis, S. aureus and coagulase negative Staphylococcus
|
Antibacterial |